In summary, both CPVT-associated variants CaM-N53I and CaM-A102V affect CaM–RyR2 structure-function relationship, resulting in Ca2+ release from the SR, via unique molecular mechanisms. The gene discussed is CALM3; the disease is catecholaminergic polymorphic ventricular tachycardia.